Varicella-Zoster Virus–Specific Antibody Responses in 50–59-Year-Old Recipients of Zoster Vaccine

Prevaccination and 6-week postvaccination samples from the immunogenicity substudy (n = 2269) of the zoster vaccine (ZV) efficacy trial (N = 22 439) in 50–59-year-old subjects were examined for varicella-zoster virus–specific antibody responses to vaccination. The varicella-zoster virus geometric me...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Infect Dis
Glavni autori: Levin, Myron J., Schmader, Kenneth E., Gnann, John W., McNeil, Shelly A., Vesikari, Timo, Betts, Robert F., Keay, Susan, Stek, Jon E., Bundick, Nickoya D., Su, Shu-Chih, Zhao, Yanli, Li, Xiaoming, Chan, Ivan S. F., Annunziato, Paula W., Parrino, Janie
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2013
Teme:
Major Articles and Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4550114/
https://ncbi.nlm.nih.gov/pubmed/23908486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jit342
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items